Navigation Links
Male impotence drugs may deserve a second look in women
Date:4/17/2009

AUGUSTA, Ga. New studies indicate the three drugs used to treat male impotence also appear to work in females, albeit a little differently, and should give the scientific community pause to take a second look at their potential in the 40 percent of women who report sexual dysfunction, researchers say.

In one of the first studies of the effect of phosphodiesterase Type 5 inhibitors - Viagra, Levitra and Cialis - on the pudendal arteries that supply the penis, vagina and clitoris the blood needed to produce a satisfying sexual experience, Medical College of Georgia researchers showed the drugs relax the artery in male and female rats.

"It shows the drugs need to be investigated more for women and small alterations could make these compounds more effective for women living with these disorders," says Dr. Kyan J. Allahdadi, postdoctoral fellow in physiology at MCG. He's presenting the findings during the 122nd Annual Meeting of the American Physiological Society held in New Orleans April 18-22 as part of the Experimental Biology 2009 scientific conference.

Although there was talk years ago of a pink pill for women to parallel the blue Viagra for men, early clinical trials found essentially no response in women.

MCG researchers decided to look again, first giving a drug to constrict the internal pudendal arteries in male and female rats as they would be in a non-erect state then giving doses of each impotency drug to see the impact. The arteries from male rats displayed a relatively standard concentration-dependent relaxation the more drug they got, the more they relaxed - while in females arteries, there was an initial relaxation then an odd oscillation between relaxation and contraction with subsequent dosing.

While they don't fully understand the swing, the unique female response likely provides more evidence that sexual function is more complex in females, says Dr. R. Clinton Webb, chair of the MCG Department o
'/>"/>

Contact: Toni Baker
tbaker@mcg.edu
706-721-4421
Medical College of Georgia
Source:Eurekalert  

6

GOOD

Page: 1 2 3

Related biology news :

1. Research could lead to new non-antibiotic drugs to counter hospital infections
2. UC Davis researchers identify a protein that may help breast cancer spread, beat cancer drugs
3. An underwater drugstore?
4. Canadian scientist mines drugs database for new diabetes treatment
5. Scientists mine drugs database for new diabetes treatment
6. Breaking the barrier: Discovery of anti-resistance factors and novel ocean drugs
7. Compounds could be new class of cancer drugs
8. In India: A search for more effective tuberculosis drugs
9. New discovery may lead to new class of allergy drugs
10. Avian flu becoming more resistant to antiviral drugs, says University of Colorado study
11. Study: Excessive use of antiviral drugs could aid deadly flu
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Male impotence drugs may deserve a second look in women
Male impotence drugs may deserve a second look in women
(Date:5/20/2012)... gauge the toxicity of quantum dots in primates has found ... a hopeful outcome for doctors and scientists seeking new ways ... which will appear on May 20 in Nature Nanotechnology ... of quantum dots in primates. The study and information in ... at 1 p.m. U.S. Eastern Standard Time. , In the ...
(Date:5/18/2012)... the rabies virus evolves in bats may depend heavily ... researchers at the University of Georgia, the U.S. Centers ... in Belgium. Their study, published May 17 in the ... geographical location was the most accurate predictor of the ... sub-tropical bat species evolved nearly four times faster than ...
(Date:5/18/2012)... we use gasoline, diesel, plastics, rubbers, and numerous ... petrochemical refinery processes. However, this is not sustainable ... Furthermore, our world is facing problems associated with ... the increasing use of fossil resources. One solution ... renewable non-food biomass for the production of chemicals, ...
Breaking Biology News(10 mins):Good news for nanomedicine: Quantum dots appear safe in pioneering study on primates 2Hitting snooze on the molecular clock: Rabies evolves slower in hibernating bats 2Hitting snooze on the molecular clock: Rabies evolves slower in hibernating bats 3Production of chemicals without petroleum 2RIKEN and Max Planck Society establish Joint Research Center for Systems Chemical Biology 19012 1Group Health Research Institute founder Dr Ed Wagner wins William B Graham Prize 81403 1Group Health Research Institute founder Dr Ed Wagner wins William B Graham Prize 81403 2Group Health Research Institute founder Dr Ed Wagner wins William B Graham Prize 81403 3AquaStar Holdings Inc s Client Receives U S Patent 7 708 944 for Portable Capillary Sensor Technology 19261 1AquaStar Holdings Inc s Client Receives U S Patent 7 708 944 for Portable Capillary Sensor Technology 19261 2
... University researcher suggests a new avenue for developing a vaccine ... viruses. , In a study published earlier this year ... mice vaccinated with a live, genetically-modified herpes simplex virus type ... being exposed to a particularly lethal "wild-type" strain of the ...
... researcher Richard H. Ebright and his collaborators have resolved key ... subject of the 2006 Nobel Prize in Chemistry. , ... to read and carry out the out instructions contained in ... as RNA polymerase, which synthesizes an RNA copy of the ...
... at Duke University have devised a new way to ... making it useful for providing longer-lasting treatment for osteoarthritis, ... drug, which would be injected directly into arthritic joints, ... few hours the unmodified drug would last, the researchers ...
Other Biology News:Research holds promise for herpes vaccine 2Nanotech tools yield DNA transcription breakthrough 2Nanotech tools yield DNA transcription breakthrough 3Nanotech tools yield DNA transcription breakthrough 4New engineered drug may offer prolonged arthritis relief 2New engineered drug may offer prolonged arthritis relief 3New engineered drug may offer prolonged arthritis relief 4
(Date:5/15/2012)... DIEGO, May 15, 2012 Cardium Therapeutics ... its financial results for the first quarter ended ... (Logo: http://photos.prnewswire.com/prnh/20051018/CARDIUMLOGO ) ... 2012 financial results, Cardium reported its goals for ... and include (1) plans to advance commercialization of ...
(Date:5/15/2012)... Connecticut and SHENZHEN, China, May 15, 2012 ... organizations, announced today that a new Roche GS FLX+ ... Shenzhen, China. The goal is to complement the existing ... long read sequencing capability. The GS FLX+ ... features the unique combination of long reads, exceptional accuracy ...
(Date:5/14/2012)... LED light with 20 times the efficiency of an ... and store data 100 times faster than those we ... if we could turn waste heat into electricity, or ... more efficient, and more accessible? , The (IEE) ... world-ranked collaborative research campus that boasts five Nobel laureates ...
(Date:5/14/2012)... May 14, 2012  More than one billion people worldwide ... decrease in the ability of the lens in the eye ... all seen others struggle with trying to read menus and ... To combat this change in vision, which often begins around ... the choices for lenses that are both multifocal ...
Breaking Biology Technology:Cardium Presents First Quarter 2012 Financial Results and Recent Developments 2Cardium Presents First Quarter 2012 Financial Results and Recent Developments 3Cardium Presents First Quarter 2012 Financial Results and Recent Developments 4Cardium Presents First Quarter 2012 Financial Results and Recent Developments 5Cardium Presents First Quarter 2012 Financial Results and Recent Developments 6Cardium Presents First Quarter 2012 Financial Results and Recent Developments 7Cardium Presents First Quarter 2012 Financial Results and Recent Developments 8Cardium Presents First Quarter 2012 Financial Results and Recent Developments 9Cardium Presents First Quarter 2012 Financial Results and Recent Developments 10Cardium Presents First Quarter 2012 Financial Results and Recent Developments 11BGI Installs Roche GS FLX+ System to Enhance Long Read Sequencing Capabilities for Genome and Transcriptome Research 2BGI Installs Roche GS FLX+ System to Enhance Long Read Sequencing Capabilities for Genome and Transcriptome Research 3Oracle chairman Jeff Henley makes $50 million gift to UC Santa Barbara 2Oracle chairman Jeff Henley makes $50 million gift to UC Santa Barbara 3Oracle chairman Jeff Henley makes $50 million gift to UC Santa Barbara 4New Daily Disposable Multifocal Contact Lenses from CooperVision Offer Comfort, Performance, Health, and Convenience to Fit Your Life 2New Daily Disposable Multifocal Contact Lenses from CooperVision Offer Comfort, Performance, Health, and Convenience to Fit Your Life 3
... PARK, N.C., June 6 Quintiles,Transnational Corp. today ... FACC, as Chief Medical and Scientific Officer. Cabell,succeeds ... Vice,President, Clinical Research Strategies., As Chief Medical ... initiatives that focus on bioethics and the protection ...
... ITMN ) today announced that John Hodgman, Senior ... at the Goldman Sachs,Twenty-Ninth Annual Global Healthcare Conference in ... PDT (11:05 a.m. EDT). Mr. Hodgman will also,present at ... Technology Conference in New York on June 12, 2008 ...
... Telik, Inc.,(Nasdaq: TELK ) announced that company ... Needham & Company Biotechnology and Medical,Technology Conference in New ... Eastern time (7:00 a.m. Pacific time). A live and ... Telik website, http://www.telik.com ., Telik, Inc. of Palo ...
Other Biology Technology:Quintiles Appoints Christopher Cabell to Chief Medical and Scientific Officer 2InterMune to Present at Goldman Sachs Healthcare and Needham & Co. Biotechnology and Medical Technology Conferences 2
mu Opioid Receptor splice variant Immunogen: Synthetic peptide corresponding to residues K S C M D R G M R N L L P D D G P R Q E of Mu Opioid Receptor. Storage: -20 C, Avoid Freeze/Thaw Cycle...
Anti-BAR Immunogen: Peptide of aa 3-21 from human Bar Available Date: 38226...
Sheep polyclonal to EBNA 3B ( Abpromise for all tested applications). Antigen: Full length protein....
NANS Immunogen: NANS (NP_061819, 260 a.a. ~ 360 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
Biology Products: